Wednesday, May 30, 2012
Sanofi, Novo, Lilly shape up for big insulin fight
LONDON (Reuters) - Competition is ramping up in the multibillion-dollar market for long-lasting insulins, with Novo Nordisk and Eli Lilly lining up new products that could trump Sanofi's top-seller Lantus.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment